Diantini Ajeng, Alfaqeeh Mohammed, Permatasari Lanny Indah, Nurfitriani Mirna, Durotulailah Lela, Wulandari Wening, Sitorus Truly Deti Rose, Wilar Gofarana, Levita Jutti
Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Padjadjaran. University, Sumedang, West Java, 45363, Indonesia.
Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Padjadjaran University, Sumedang, West Java, 45363, Indonesia.
Pediatric Health Med Ther. 2024 Jul 11;15:243-255. doi: 10.2147/PHMT.S468314. eCollection 2024.
Cough and cold symptoms (CCS) are common pediatric conditions often treated with over-the-counter (OTC) medications. However, the available knowledge regarding the safety and toxicity of these medications in children is inadequate. Therefore, understanding their clinical toxicology is crucial for safeguarding children's well-being. This narrative review highlights the importance of clinical toxicology in evaluating the safety and toxicity profile of OTC medications for treating CCS in pediatric patients. The pharmacology, clinical features, and adverse effects of various drug classes commonly found in cough and cold medications are briefly discussed. Pharmacokinetic and pharmacodynamic parameters are also examined to understand the interactions between these drugs and the body. OTC cough and cold medications often contain active ingredients such as antihistamines, decongestants, antitussives, expectorants, and analgesics-antipyretics. The combination of multiple ingredients in these products significantly increases the risk of adverse effects and unintentional overdoses. Several case studies have reported significant toxicity and even fatalities associated with the use of these medications in children. This review underscores the critical importance of clinical toxicology in evaluating the safety and toxicity profile of OTC medications employed for treating CCS in pediatric patients. The findings highlight the significance of informed clinical practice and public health policies to ensure the well-being of children using OTC cough and cold medications.
咳嗽和感冒症状(CCS)是常见的儿科病症,通常使用非处方(OTC)药物进行治疗。然而,关于这些药物在儿童中的安全性和毒性的现有知识并不充分。因此,了解它们的临床毒理学对于保障儿童的健康至关重要。这篇叙述性综述强调了临床毒理学在评估用于治疗儿科患者CCS的OTC药物的安全性和毒性概况方面的重要性。简要讨论了咳嗽和感冒药中常见的各类药物的药理学、临床特征和不良反应。还研究了药代动力学和药效学参数,以了解这些药物与人体之间的相互作用。OTC咳嗽和感冒药通常含有抗组胺药、减充血剂、止咳药、祛痰药和止痛退烧药等活性成分。这些产品中多种成分的组合显著增加了不良反应和意外过量用药的风险。几项案例研究报告了儿童使用这些药物后出现的严重毒性甚至死亡情况。本综述强调了临床毒理学在评估用于治疗儿科患者CCS的OTC药物的安全性和毒性概况方面的至关重要性。研究结果突出了明智的临床实践和公共卫生政策对于确保使用OTC咳嗽和感冒药的儿童健康的重要性。